✦ LIBER ✦

Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk

✍ Scribed by A. F. H. Stalenhoef; M. H. Davidson; J. G. Robinson; T. Burgess; R. Duttlinger-Maddux; D. Kallend; A. C. Goldberg; H. Bays

Book ID: 109046221
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 586 KB
Volume: 14
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2011.01485.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of peripheral total and diff

Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus

✍ Jack C.-R. Tsai; Sheng-Hsiung Sheu; Herng-Chia Chiu; Fu-Mei Chung; Dao-Ming Chan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 3 views

Putting the diabetes prevention program

Putting the diabetes prevention program into practice: A program for weight loss and cardiovascular risk reduction for patients with metabolic syndrome or type 2 diabetes mellitus

✍ Patrick E. McBride; J. A. Einerson; H. Grant; C. Sargent; G. Underbakke; M. Vitc 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 114 KB

Bone quantitative ultrasound measurement

Bone quantitative ultrasound measurements in relation to the metabolic syndrome and type 2 diabetes mellitus in a cohort of elderly subjects at high risk of cardiovascular disease from the predimed study

✍ Mònica Bulló; M. Garcia-Aloy; J. Basora; M. I. Covas; J. Salas-Salvado 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 90 KB

Ezetimibe added to atorvastatin compared

Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither

✍ S. Conard; H. Bays; L. A. Leiter; S. Bird; J. Lin; M. E. Hanson; A. Shah; A. M. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

Dobutamine stress echocardiography: fals

Dobutamine stress echocardiography: false positive scans in proteinuric patients with Type 1 diabetes mellitus at high risk of ischaemic heart disease

✍ Griffin, M.E.; Nikookam, K.; Teh, M.M.; McCann, H.; O’Meara, N.M.; Firth, R.G. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 2 views

Patients with Type 1 diabetes mellitus have an increased risk of ischaemic heart disease (IHD). When diabetes is complicated by nephropathy this risk is further increased and asymptomatic IHD is common. New techniques for non-invasive cardiac evaluation are now available and one of these, Dobutamine

Efficacy and safety of the dipeptidyl pe

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin

✍ K. Hermansen; M. Kipnes; E. Luo; D. Fanurik; H. Khatami; P. Stein; Sitagliptin S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB